Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are able to give written agreement to take part, either themselves or through a legally authorised representative.
- People aged between 45 and 75 years (inclusive).
- People who have completed at least primary school education.
- People who have been diagnosed within the Alzheimer's disease spectrum according to recognised international diagnostic criteria (the National Institute on Aging and Alzheimer's Association criteria).
- People with mild memory or thinking difficulties due to Alzheimer's disease, confirmed by specific scores on two standard assessments (the Montreal Cognitive Assessment and the Clinical Dementia Rating scale).
- People with confirmed evidence of Alzheimer's disease-related changes in the brain, shown through a brain scan, spinal fluid test, or blood test.
- People whose Alzheimer's disease-related medications are expected to stay the same throughout the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with a current or past history of a neurological condition other than Alzheimer's disease that may affect thinking or test results, such as epilepsy, stroke, multiple sclerosis, poorly controlled migraines, brain injury, previous brain surgery, or head trauma with lasting neurological effects.
- People for whom brain scans (MRI), brain activity recordings (EEG), sound-based stimulation, light-based stimulation, or non-invasive brain stimulation are not safe or suitable.
- People currently experiencing major depression or another mental health condition that, in the treating doctor's judgement, may interfere with taking part in the study or affect the results.
- People with significant structural abnormalities found on a brain MRI scan, such as fluid build-up in the brain, stroke, or other structural changes that could affect study results.
- People with severe heart or lung disease.
- People whose main cause of cognitive impairment appears to be a condition other than Alzheimer's disease, such as frontotemporal dementia, dementia with Lewy bodies, Parkinson's disease dementia, or vascular dementia.
- People who are considered to have a significant risk of suicide, or who have made a suicide attempt in the past 12 months.
- People with significant behavioural difficulties, such as severe aggression, agitation, or impulsivity, that may make it hard to follow study procedures.
- People who are currently receiving, or plan to receive, a specific type of medication called an anti-amyloid monoclonal antibody during the study.
- People who have any other condition that, in the treating doctor's judgement, makes participation in the study unsuitable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
If you need support right now
This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.
If you or someone else is in immediate danger, call 000.
- Lifeline — 24/7 crisis support: 13 11 14
- Suicide Call Back Service — 24/7 counselling: 1300 659 467
- 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
- Beyond Blue — 24/7 mental health support: 1300 22 4636
- Emergency: 000
Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.
Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.
Contact this trial
Principal Investigator: Yue Huang, Beijing Tiantan Hospital
Phone: +8619801177703
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Change From Baseline in Alzheimer's Disease Assessment Scale-Cognitive Subscale Score; Incidence of Treatment-Emergent Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.